Journal article
Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease.
Authors
Marshall JK
Journal
Annals of Internal Medicine, Vol. 148, No. 4,
Publisher
American College of Physicians
Publication Date
June 17, 2008
DOI
10.7326/0003-4819-148-12-200806170-02009
ISSN
1056-8751